Royalty Pharma Plc (RPRX)
39.15
-0.45
(-1.14%)
USD |
NASDAQ |
Dec 04, 16:00
39.14
-0.01
(-0.03%)
After-Hours: 20:00
Royalty Pharma Total Assets (Quarterly): 19.35B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 4.852B |
| Zenas BioPharma, Inc. | 322.02M |
| Amgen, Inc. | 90.14B |
| Eli Lilly & Co. | 114.94B |
| Pfizer Inc. | 208.73B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 9.726B |
| Shareholders Equity (Quarterly) | 6.414B |
| Debt to Equity Ratio | 1.397 |
| Current Ratio | 3.484 |
| Net Debt Paydown Yield | -1.80% |